Alzheimer's Disease and Exercise: A Literature Review
1Sports Medicine, University of New Mexico, Albuquerque, NM.
Current Sports Medicine Reports
|January 10, 2017
Summary
Regular exercise may help prevent and treat Alzheimer's disease (AD) by improving brain health and cognitive function. Physical activity offers a safer alternative to medications for managing AD symptoms and daily living activities.
Area of Science:
- Neuroscience
- Gerontology
- Public Health
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder leading to dementia, significantly impacting the elderly.
- Current medications for AD have mixed effectiveness, highlighting the need for alternative strategies.
- Physical inactivity is a major preventable risk factor for AD development.
Purpose of the Study:
- To evaluate the role of exercise as a treatment and prevention strategy for Alzheimer's disease.
- To explore the effects of exercise on cognitive function, brain health, and daily living activities in AD patients.
- To compare the efficacy and tolerability of exercise versus pharmacological interventions for AD.
Main Methods:
- Review of prospective studies and clinical evidence on exercise interventions for AD.
- Analysis of exercise's impact on neurobiological markers such as hippocampal volume and neurogenesis.
- Assessment of exercise's effects on cognitive performance and neuropsychiatric symptoms.
Main Results:
- Exercise improves brain blood flow, increases hippocampal volume, and promotes neurogenesis.
- Higher physical activity levels are associated with a reduced risk of developing AD.
- Exercise demonstrates improvements in cognitive function, reduced neuropsychiatric symptoms, and slower decline in activities of daily living (ADL).
Conclusions:
- Exercise is a promising strategy for managing pre-clinical, late-stage AD, and prevention.
- Exercise offers a safer, more tolerable alternative to medications for AD treatment with better adherence.
- Promoting physical activity is crucial for mitigating AD risk and improving patient outcomes.
Related Concept Videos
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Exercise and Cardiovascular Response
4.8K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.8K
Dementia
633
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
633
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K


